{"SPADE_UN_11331": {"basic": {"SPADE ID": "SPADE_UN_11331", "Peptide Name": "p2TA(AB103, Reltecimod)", "Sequence": "ASPMLVAYDA", "Source": "Reltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections).", "Biological Activity": ["Antibacterial"], "Target Organism": "No MICs found on DRAMP database"}, "extended_data_url": "SPADE_UN_11331_extended.json"}}